Kern JA - Search Results

1

Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway.

Liu J, Nethery D, Kern JA. Liu J, et al. Among authors: kern ja. Exp Lung Res. 2004 Sep;30(6):465-78. doi: 10.1080/01902140490476454. Exp Lung Res. 2004. PMID: 15524405 Free article.

2

Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.

Liu J, Kern JA. Liu J, et al. Among authors: kern ja. Am J Respir Cell Mol Biol. 2002 Sep;27(3):306-13. doi: 10.1165/rcmb.4850. Am J Respir Cell Mol Biol. 2002. PMID: 12204892

3

Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines.

Gollamudi M, Nethery D, Liu J, Kern JA. Gollamudi M, et al. Among authors: kern ja. Lung Cancer. 2004 Feb;43(2):135-43. doi: 10.1016/j.lungcan.2003.08.027. Lung Cancer. 2004. PMID: 14739033

4

Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy.

Dowlati A, Nethery D, Kern JA. Dowlati A, et al. Among authors: kern ja. Mol Cancer Ther. 2004 Apr;3(4):459-63. Mol Cancer Ther. 2004. PMID: 15078989

5

Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice.

Nethery DE, Moore BB, Minowada G, Carroll J, Faress JA, Kern JA. Nethery DE, et al. Among authors: kern ja. J Appl Physiol (1985). 2005 Jul;99(1):298-307. doi: 10.1152/japplphysiol.01360.2004. Epub 2005 Feb 24. J Appl Physiol (1985). 2005. PMID: 15731393 Free article.

6

Acute lung injury augments hypoxic ventilatory response in the absence of systemic hypoxemia.

Jacono FJ, Peng YJ, Nethery D, Faress JA, Lee Z, Kern JA, Prabhakar NR. Jacono FJ, et al. Among authors: kern ja. J Appl Physiol (1985). 2006 Dec;101(6):1795-802. doi: 10.1152/japplphysiol.00100.2006. Epub 2006 Aug 3. J Appl Physiol (1985). 2006. PMID: 16888052 Free article.

7

Inactivation of neuregulin-1 by nitration.

Nethery DE, Ghosh S, Erzurum SC, Kern JA. Nethery DE, et al. Among authors: kern ja. Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L287-93. doi: 10.1152/ajplung.00058.2006. Epub 2006 Sep 15. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 16980377 Free article.

8

Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.

Cortas T, Eisenberg R, Fu P, Kern J, Patrick L, Dowlati A. Cortas T, et al. Lung Cancer. 2007 Mar;55(3):349-55. doi: 10.1016/j.lungcan.2006.11.003. Epub 2006 Dec 8. Lung Cancer. 2007. PMID: 17161498

9

Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.

Faress JA, Nethery DE, Kern EF, Eisenberg R, Jacono FJ, Allen CL, Kern JA. Faress JA, et al. Among authors: kern ef, kern ja. J Appl Physiol (1985). 2007 Dec;103(6):2077-83. doi: 10.1152/japplphysiol.00239.2007. Epub 2007 Oct 4. J Appl Physiol (1985). 2007. PMID: 17916677 Free article.

10

SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2.

Dowlati A, Kluge A, Nethery D, Halmos B, Kern JA. Dowlati A, et al. Among authors: kern ja. Anticancer Drugs. 2008 Jan;19(1):9-16. doi: 10.1097/CAD.0b013e3282f1a908. Anticancer Drugs. 2008. PMID: 18043125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters